Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
Creates new international network of scientific excellence for large-scale biocatalysis.
October 25, 2021
By: Charlie Sternberg
The Olon Group has created an international network of scientific excellence to launch large-scale biocatalysis as an industrial technology used within its production facilities in Italy and around the world. The partnership, bringing together some of the most advanced expertise in the field of biocatalysis from both academic and industrial spheres, unites the Olon Group, Biosphere—an Italian SME specialized in fermentation and industrial biotechnology—and the Biocatalysis Group of the Van’t Hoff Institute for Molecular Sciences (HIMS-Biocat) at the University of Amsterdam (UvA). The HIMS-Biocat group, headed by Prof. Francesco Mutti, has pioneered ground-breaking research in the area of enzyme engineering and the use of enzymes for performing novel, sustainable and “green” chemical reactions. The partnership forms part of a wider Olon Group strategy involving long-term investment in the in-house development of advanced technology, applied in the production of active ingredients, with biotechnology as one of its highest priorities. “Biotechnology enables us to develop more sustainable chemical processes, reducing environmental impacts and increasing cost-effectiveness, to the benefit of our partners. The process certainly becomes more efficient and the reduction in environmental impacts is considerable,” commented Olon Group CEO, Paolo Tubertini. “We have acted as a catalyst and aggregator for international excellence, thanks to a rapid and flexible approach that enables us to introduce top expertise to our processes, quickly and sustainably, and make this available to our partners. In our vision, this is a first step that, over the coming years, will lead us to convert a portion of our existing reactions to biocatalysis, and to develop new reactions with this new technology,” continued Tubertini. With the expertise implemented by the University of Amsterdam and Biosphere, it will be possible to identify the most effective enzyme for the type of reaction required before scaling up its production to industrial levels. Biosphere is an Italian leader in the sector, with a mission to implement biotechnology in industrial processes with a circular economy approach. “We are proud to be members of this strategic partnership promoted by Olon. Biocatalysis is surely one of the most promising solutions to introduce innovation in chemical synthesis, and the aim of this project is to put together solid outstanding academic research and industrial vision and capabilities, to develop new production routes that will be both environmentally and economically sustainable,” said Marco Pistocchi, chief operating officer of Biosphere. “We joined this partnership with great enthusiasm as it will also allow us to make a wider impact on society, industry and environment. Our major aims are to develop new biocatalysts and biocatalytic systems for the sustainable and efficient synthesis of organic molecules that are relevant for the chemical industry as well as to address fundamental questions of bioorganic chemistry and biochemistry. We believe that the advancement in the field of biocatalysis can meet the changing needs of industry and has a decisive impact on the future of the next generations on our planet,” added Prof. Francesco Mutti from the University of Amsterdam.
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !